PANI, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 152.867
NA - Nord America 8.259
AS - Asia 3.242
SA - Sud America 462
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 164.894
Nazione #
IT - Italia 150.293
US - Stati Uniti d'America 8.177
CN - Cina 1.608
SG - Singapore 1.114
UA - Ucraina 825
SE - Svezia 574
DE - Germania 381
BR - Brasile 380
GB - Regno Unito 286
FI - Finlandia 208
VN - Vietnam 158
KR - Corea 100
FR - Francia 98
IN - India 82
CA - Canada 52
AR - Argentina 40
RU - Federazione Russa 36
HK - Hong Kong 32
PL - Polonia 32
BD - Bangladesh 25
NL - Olanda 25
BE - Belgio 22
MX - Messico 20
ES - Italia 18
JP - Giappone 16
EC - Ecuador 15
TR - Turchia 13
ID - Indonesia 12
IE - Irlanda 12
IQ - Iraq 11
MA - Marocco 11
ZA - Sudafrica 11
CZ - Repubblica Ceca 9
MU - Mauritius 9
AT - Austria 8
LT - Lituania 8
PK - Pakistan 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CO - Colombia 6
JO - Giordania 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
EG - Egitto 5
EU - Europa 5
IL - Israele 5
KE - Kenya 5
RO - Romania 5
AZ - Azerbaigian 4
IR - Iran 4
NG - Nigeria 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
MY - Malesia 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PT - Portogallo 2
TN - Tunisia 2
UY - Uruguay 2
BG - Bulgaria 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 164.894
Città #
Cagliari 147.523
Uta 2.292
Woodbridge 735
Fairfield 733
Chandler 706
Ashburn 653
Singapore 592
Houston 551
Boardman 458
Jacksonville 452
Ann Arbor 434
Wilmington 377
Dallas 368
Nyköping 336
Beijing 314
Seattle 287
Cambridge 247
Dearborn 207
Hefei 179
Nanjing 147
Shanghai 111
Santa Clara 109
Los Angeles 105
Boston 98
Seoul 93
New York 91
Buffalo 86
Helsinki 75
Milan 67
Shenyang 63
Nanchang 58
Ho Chi Minh City 53
Guangzhou 49
Hebei 40
Jiaxing 39
Redwood City 38
São Paulo 37
San Diego 36
Verona 35
Rome 30
Hanoi 29
Changsha 28
Dong Ket 28
Jinan 28
Mountain View 27
Toronto 27
Falls Church 25
Hong Kong 25
Warsaw 25
Tianjin 24
Brooklyn 23
Munich 22
Brussels 20
Pune 20
Redondo Beach 20
Zhengzhou 19
Norwalk 18
The Dalles 18
Washington 18
London 17
San Francisco 16
Phoenix 14
Auburn Hills 13
Stockholm 13
Tokyo 13
Montreal 12
Orange 12
Palermo 12
Rio de Janeiro 12
Kunming 11
Ningbo 11
Dublin 10
Sassari 10
Taizhou 10
Atlanta 9
Chennai 9
Chicago 9
Curitiba 9
Hangzhou 9
Mumbai 9
Amsterdam 8
Columbus 8
Denver 8
Haiphong 8
Manchester 8
Wuhan 8
Brno 7
Frankfurt am Main 7
Indiana 7
Johannesburg 7
San Vittore 7
Augusta 6
Council Bluffs 6
Düsseldorf 6
Guarulhos 6
Jakarta 6
Leawood 6
Mexico City 6
Nuremberg 6
Orem 6
Totale 159.725
Nome #
Mixed thiophene-phenanthroline Cu(II) complexes: synthesis, equilibria and cytotoxicity 4.794
Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study 4.306
Mixed thiophene-phenanthroline Cu (II) complexes: synthesis, antiviral and antiproliferative activity 4.159
1H NMR brain metabonomics of scrapie exposed sheep 3.981
Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4) 3.932
Novel coumarins and related copper complexes with biological activity: DNA binding, molecular docking and in vitro antiproliferative activity 3.642
Lipid profiles in brains from sheep with natural scrapie 3.448
Mixed-1,10-phenanthroline-Cu(II) complexes: Synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione 3.288
Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks 3.212
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.168
Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC 3.164
New Ruthenium (III) complexes with antitumor activity: design, synthesis and characterization 3.094
null 3.087
Platinum complexes with 1,10-phenanthroline derivatives: synthesis, kinetics and in vitro cytotoxicity. 3.063
A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients 2.984
Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells 2.972
Synergistic effects of copper(II) complexes and cisplatin: an application of artificial neural networks and experimental design 2.863
Synergistic cytotoxicity of copper(II) complexes in combination with cisplatin: an application of artificial neural networks and experimental design 2.801
Cisplatin, glutathione and the third wheel: a copper-(1,10-phenthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin 2.621
Biochemical and molecular modifications in sheep brains during natural scrapie. 2.585
RT-QuIC detection of PrPsCJD spiked into human urine 2.561
RT-QuIC assay for the detection of PrPsCJD spiked into human urine 2.561
Drug Discovery: towards the identification and characterization of new lead compounds as anticancer and antiprion agents 2.495
Drug Discovery: towards the identification and characterization of new lead compounds for the design of new anticancer and antiprion agents 2.473
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease 2.456
Altered cholesterol ester cycle in ex vivo skin fibroblasts from Alzheimer patients 2.419
Biochemical and molecular modifications in sheep brains during natural scrapie 2.391
Accumulation and aberrant composition of cholesteryl esters in Scrapie-infected N2a cells and C57BL/6 mouse brains 2.279
Cholesterol homeostasis and prion misfolding: a comparative study in mouse neuroblastoma cells and in sheep brains and skin fibroblasts 2.256
Lipid derangement and prion misfolding in prion infected mouse neuroblastoma cells lines and in brains and skin fibroblasts from scrapie-susceptible sheep 2.254
Altered proteolysis in fibroblasts of alzheimer patients with predictive implications for subjects at risk of disease 2.226
Intra and intercellular distribution pf mitochondrial probes: a comparison between TMRM and JC-1 2.180
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays 2.104
Systemic alteration of Cholesterol Homeostasis in experimental and natural scrapie 2.066
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays. XII Congresso Federazione Italiana Scienze della Vita (FISV). Universita` La Sapienza Roma (Italia), 24-27 Settembre 2012. 2.039
Studies on role of cholesterol in the pathogenesis of prion disorders 2.037
null 1.934
Accumulation and aberrant composition of cholesteryl esters in in vitro and in vivo models of prion-infection 1.867
null 1.848
Accumulation and aberrant composition of cholesteryl esters in in vitro and in vivo models of prion-infection 1.799
Ultrasensitive detection of prion seeding activity by RT-QuIC and eQuIC assays for early diagnosis of prion diseases 1.691
null 1.664
Cholesterol Metabolism in Brain and Skin Fibroblasts from Sarda Breed Sheep With Scrapie-resistant and Scrapie-susceptible Genotypes 1.649
ACAT1, Cav-1, and PrP expression in brains and skin fibroblasts from Sarda breed sheep with scrapie-resistant and scrapie-susceptible genotype 1.201
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.199
Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746. 1.196
null 1.142
1 ß ribofuranosyl pyrazolo derivati e relativo processo di produzione e impiego farmacologico 1.141
Neurodegenerative diseases and protein misfolding: novel targets and new inhibitors 1.140
null 1.133
Synthesis and biological evaluation of 5H-indolo [3,2-b][1,5]benzothiazepine derivatives, designed as conformationally constrained analogues of the human immunodeficiency virus type 1 reverse transcriptase inhibitor L-737,126. 1.066
MDR1 cholesterol esterification and cell growth. A comparative study in normal and multidrug resistant KB cell lines 984
Changes in cholesterol metabolism in peripheral cells of Alzheimer disease patients and their relatives 953
Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition 952
Possibile nuovo biomarker diagnostico di malattia di Alzheimer: gli esteri del colesterolo 905
Derivatives of the new ring system indolo (1,2-c) benzo (1,2,3) triazine with potent antitumor and antimicrobial activity 840
Intra- and intercellular distribution of mitochondrial probes and changes after treatment with MDR modulators 761
Synthesis, solution equilibria and cytotoxic activity of new copper(II) complexes with 1,10-phenanthroline derivatives 751
Correlation between cholesterol esterification MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines 747
Cholesterol metabolism in brain and skin fibroblasts from Sarda breed sheep with scrapie resistant or susceptible genotype 721
Protein misfolding diseases: novel targets and new inhibitors 681
Synthesis, structural characterisation, complex formation constants and in vitro cytotoxicity of some copper(II) complexes 630
Pharmacologic cholesterol homeostasis affects prion generation in a synergistic manner 613
Synthesis and antiproliferative acticity of basic thioanalogues of merbarone 593
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 588
Nuovi composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus 585
Pyrazole related nucleosides. Synthesis and antiviral / antitumor activity of some substituted pyrazole and pyrazolo [4,3-d]1,2,3-triazin-4-one nucleosides 582
Antiviral activity of glycyrrhizic acid 577
Glycyrrhizic acid inhibits virus growth and inactivates virus particles 550
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells 534
Influence of hydrocortisone on cytopathic effect of Newcastle disease virus and stability to freezing of vescicular stomatitis virus 515
Translational control in L-cells infected by Vesicular Stomatitis Virus or Mengovirus 503
Anti-prion activity of cholesterol esterification modulators: a comparative study in ex vivo sheep fibroblasts and lymphocytes and in mouse neuroblastoma cell lines 495
Inactivation by freezing of vesicular stomatitis virus treated with hydrocortisone 492
Prpspettive in tema di antivirali 490
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration 490
Pyrazole-related nucleosides. Design, synthesis and antiproliferative activity of methyl 4-iodo-1--D -ribofuranosyl-pyrazole-3-carboxylate (IPCAR) and derivatives, against human leukemia, lymphoma and solid tumor cell lines in vitro 488
On the inhibitory effect of 2-amino-4,6-pyrimidines. 481
Oligodeossinucleotidi nativi selettivamente attivi in vitro contro il virus dell'immunodeficienza umana di tipo 1: ruolo del G-quartet. 462
Synthesis of new disoxaril analogues with potent and selective anti-HRV-14 activity 442
Variation in resistance of cells from inbred strains of mice to herpes simplex virus type 1 437
Characterization and role in morphogenesis of a new subviral particle (55S) isolated from polio infected cells 418
Synthesis, biological evaluation and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitro imidazoles targeted at the HIV-1 reverse transcriptase 418
A Kinase able to phosphorylate exogenous protein synthesis initiation factor eIF 2a is present in lysates of mengovirus infected L cells 412
Poliovirus morphogenesis. I. Identification of 80S dissociable particles and evidence for the artefactual production of procapsids 408
Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients 404
On the antiviral action of glycyrrhized acid. II. Non involvement of cell membrane transport of ions and metabolites in the antiviral effect 400
Accumulation of cholesterol esters in ex vivo lymphocytes from scrapie-susceptible sheep and in scrapie-infected mouse neuroblastoma cell lines 394
Prophylactic and/or therapeutic treatment of proliferative and conformational diseases 392
HIV-1 integrase inhibitors that block HIV-1 replication in infected cells: planning synthetic derivatives from natural products 390
Perspectives in antiviral chemotherapy 389
Neutral Lipid Determination in Peripheral Blood Mononuclear Cells: A Useful Tool for Diagnostic and Therapeutic Interventions in Dementia 386
CELL GROWTH AND CHOLESTEROL ESTERS 378
null 374
Models for viral resistance or dependence 368
Design, Synthesis, SAR, and Molecular Modeling Studies of Acylthiocarbamates: A Novel Series of Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Structurally Related to Phenethylthiazolylthiourea Derivatives 363
null 362
Antiherpes activity of 5 (2 bromoethyl)2' deoxyuridine 357
null 357
null 353
Totale 151.796
Categoria #
all - tutte 210.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116.055 0 0 0 0 0 4.620 3.278 2.470 1.038 2.031 1.593 1.025
2021/20228.256 794 899 465 592 895 617 578 349 473 779 843 972
2022/202310.222 949 1.074 1.166 912 978 1.206 433 817 733 637 823 494
2023/202411.274 573 498 530 827 1.073 1.557 1.708 818 565 833 1.250 1.042
2024/202517.322 2.468 5.066 2.680 1.885 1.278 1.269 1.498 150 283 161 242 342
2025/20263.219 423 441 847 624 583 301 0 0 0 0 0 0
Totale 165.043